Analgesic effects of 5‐HT₃ receptor antagonists

References

• Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765–9.
   PubMed Web of Science ®Google Scholar
• Schadrack J, Zieglgansberger W. Activity-dependent changes in the pain matrix. Scand J Rheumatol 2000;29 Suppl 113:19–23.
   Google Scholar
• Zieglgansberger W. Pain perception: a dynamic process. Anaesthesist 2002;51:349–50.
   PubMedGoogle Scholar
• Schadrack J, Zieglgansberger W. Pharmacology of pain processing systems. Z Rheumatol 1998;57 Suppl 2:1–4.
   PubMedGoogle Scholar
• Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083–152.
   PubMed Web of Science ®Google Scholar
• Yakel JL. The 5-HT3 receptor channel: function, activation and regulation. In: Endo M, ed. Pharmacology of ionic channel function: Activators and inhibitors. Berlin-New York: Springer 2000:541–60.
   Google Scholar
• Hille B. Ion Channels of excitable membranes. Sunderland, MA, USA: Sinauer Associates, 3rd Ed, 2001.
   Google Scholar
• Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, et al. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 1999;397:359–63.
   PubMed Web of Science ®Google Scholar
• Dubin AE, Huvar R, D'Andrea MR, Pyati J, Zhu JY, Joy KC, et al. The pharmacological and functional char-acteristics of the serotonin 5-HT (3A) receptor are specifically modified by a 5-HT (3B) receptor subunit. J Biol Chem. 1999;274: 30799–810.
   Google Scholar
• Hapfelmeier G, Tredt C, Haseneder R, Zieglgansberger W, Eisensamer B, Rupprecht R, et al. Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J 2003;84:1720–33.
   PubMed Web of Science ®Google Scholar
• Richardson BP, Engel G, Donatsch P, Stadler PA. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985;316:126–31.
   PubMed Web of Science ®Google Scholar
• Sufka KJ, Schomburg FM, Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 1992;41: 53–6.
   Google Scholar
• Giordano J, Daleo C, Sacks SM. Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 1998;354:R13–4.
   Google Scholar
• Giordano J, Rogers LV. Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol 1989;170:83–6.
   PubMed Web of Science ®Google Scholar
• Moser PC. The effect of 5-HT3 receptor antagonists on the writhing response in mice. Gen Pharmacol 1995;26:1301–06.
   PubMedGoogle Scholar
• Doak GJ, Sawynok J. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxy-tryptamine receptor subtypes. Neuroscience 1997;80:939–49.
   PubMed Web of Science ®Google Scholar
• Muller W, Stratz T. 5-HT3-receptor-antagonists in therapy of rheumatic diseases. Z Rheumatol 2003;62:39–41.
   PubMed Web of Science ®Google Scholar
• Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WJ, Sun L, et al. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002;22:1010–19.
   PubMed Web of Science ®Google Scholar
• Khan NA, Hichami A. Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospho-lipase D pathway in human T-cells. Biochem J 1999;344: 199–204.
   PubMed Web of Science ®Google Scholar
• Khan NA, Poisson JP. 5-HT3 receptor-channels coupled with Na influx in human T cells: role in T cell activation. J Neuroimmunol 1999;99:53–60.
   PubMed Web of Science ®Google Scholar
• Meyniel JP, Khan NA, Ferriere F, Deschaux P. Identification of lymphocyte 5-HT3 receptor subtype and its implication in fish T-cell proliferation. Immunol Lett 1997;55:151–60.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Ishizaki K, Obata H, Goto F. Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmis-sion in rat spinal cord according to the formalin test. Eur J Pharmacol 2001;424:45–52.
   PubMedGoogle Scholar
• Glaum SR, Proudfit HK, Anderson EG. 5-HT3 receptors modulate spinal nociceptive reflexes. Brain Res 1990;510: 12–16.
   Google Scholar
• Kukushkin ML, Igon'kina SI. Role of 5-HT3 receptors in the mechanisms of central pain syndrome. Bull Exp Biol Med 2003;135: 552–5.
   Google Scholar
• Kawamata T, Omote K, Toriyabe M, Yamamoto H, Namiki A. The activation of 5-HT(3) receptors evokes GABA release in the spinal cord. Brain Res 2003;978: 250–5.
   Google Scholar
• Alhaider AA, Lei SZ, Wilcox GL. Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci 1991;11: 1881–8.
   Google Scholar
• Ali Z, Wu G, Kozlov A, Barasi S. The role of 5HT3 in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci Lett 1996;208:203–7.
   PubMed Web of Science ®Google Scholar
• Olivier B, van Wijngaarden I, Soudijn W. 5-HT (3) receptor antagonists and anxiety; a preclinical and clinical review. Eur Neuropsychopharmacol 2000;10:77–95.
   PubMed Web of Science ®Google Scholar
• Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G, et al. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry 2003;8:994–1007.
   PubMed Web of Science ®Google Scholar
• Greenshaw AJ, Silverstone PH. The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology
   Google Scholar
• Fan P. Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones.
   Google Scholar
• Fan P. Inhibition of a 5-HT3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine. Neurosci Lett
   Google Scholar
• Costa B, Naylor RJ. Astra Award Lecture. The psycho-pharmacology of 5-HT3 receptors. Pharmacol Toxicol
   Google Scholar
• Farber L, Stratz T, Bruckle W, Spatz M, Pongratz D, Lautenschlager J, et al. Efficacy and tolerability of tropisetron
   Google Scholar
• Farber L, Stratz TH, Bruckle W, Spath M, Pongratz D,
   Google Scholar
• Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scand J Rheumatol 2000;29 Suppl
   Google Scholar
• Muller W, Stratz T. 5-HT3-receptor-antagonists in therapy of rheumatic diseases. Z Rheumatol 2003;62:39–41.
   PubMed Web of Science ®Google Scholar
• Hart FD. Fibrositis (Fibromyalgia). A common non-entity?
   Google Scholar
• Stratz T, Schochat T, Farber L, Schweiger C, Muller W. Are there subgroups in fibromyalgia? Musculoskel Pain 1995;
   Google Scholar
• Stratz T, Muller W. Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron. Schmerz
   Google Scholar
• Ernberg M, Lundeberg T, Kopp S. Effects on muscle pain by intramuscular injection of granisetron in patients with
   Google Scholar
• Voog 0, Alstergren P, Leibur E, Kallikorm R, Kopp S.
   Google Scholar
• Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ Jr. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003;102: 87–95.
   Google Scholar
• Brown AM. Ion permeation and conduction in human recombinant 5-HT3 receptor subunit (h5-HT3A). J Physiol 1998;507:653–65.
   PubMedGoogle Scholar
• Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D. Primary structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion channel. Science 1991;254: 432–7.
   Google Scholar
• Linhart 0, Obreja 0, Kress M. The inflammatory mediators serotonin, prostaglandin E2 and bradykinin evoke calcium influx in rat sensory neurons. Neuroscience 2003;118: 69–74.
   Google Scholar
• Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. CUrr Pain Headache Rep 2003;7:355–61.
   PubMedGoogle Scholar
• Muller W, Stratz T. Results of the intravenous administration of tropisetron in fibromyalgia patients. Scand J Rheumatol 29 2000; Suppl 113:59–62.
   Google Scholar
• Stratz T, Varga B, Muller W. The influence of depression on the effect of tropisetron in the therapy of fibromyalgia. Z Rheumatol 2003;62:42–5.
   Google Scholar
• Lembo A, Weber HC, Farraye FA. Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder. Drugs 2003;63:1895–1905.
   Google Scholar
• Shaath NM, Whorwell PJ. 5-HT and the treatment of irritable bowel syndrome: A clinical perspective. Drugs Today 2001;37:437–40.
   PubMedGoogle Scholar
• Devlin J, Wagstaff K, Arthur V, Emery P. Granisetron (Kytril) suppresses methotrexate-induced nausea and vomiting among patients with inflammatory arthritis and is superior to prochlorperazine (Stemetil). Rheumatology 1999;38:280–2.
   PubMed Web of Science ®Google Scholar
• Oz M, Zhang L, Spivak CE. Direct non-competitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids. Arch Biochem Biophys 2002;404: 293–301.
   Google Scholar
• Sandrini M, Pini LA, Vitale G. Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the anti-nociceptive effect of paracetamol. Infiamm Res 2003;52: 347–52.
   Google Scholar
• Sandrini M, Vitale G, Pini LA. Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes. Pharmacology 2002;65:193–7.
   Google Scholar
• Nicholson R, Small J, Dixon AK, Spanswick D, Lee K. Serotonin receptor mRNA expression in rat dorsal root ganglion neurons. Neurosci Lett 2003;337:119–22.
   Google Scholar
• Morales M, Wang SD. Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci 2002;22:6732–41.
   PubMed Web of Science ®Google Scholar
• van Hooft JA, Yakel JL. 5-HT3 receptors in the CNS: 3B or not 3B? Trends Pharmacol Sci 2003;24: 157–60.
   Google Scholar
• Miller LG, Galpem WR, Dunlap K, Dinarello CA, Turner TJ. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain. Mol Pharmacol 1991;39: 105–8.
   Google Scholar
• Miller LG, Fahey JM. Interleukin-1 modulates GABAergic and glutamatergic function in brain. Ann NY Acad Sci 1994;739:292–8.
   PubMed Web of Science ®Google Scholar
• Wang S, Cheng Q, Malik S, Yang J. Interleukin-lbeta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 2000;292:497–504.
   PubMed Web of Science ®Google Scholar